RNA interference and human disease

Molecular Genetics and Metabolism

Volumn 80, Issue 1-2, 2003, Pages 121-128

  Cheng, Jerry C ^a   Moore, Theodore B ^a   Sakamoto, Kathleen M ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; LENTIVIRUS VECTOR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

DNA MICROARRAY; GENE REPRESSION; HISTAMINE RELEASE; HUMAN; ONCOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA GENE; SHORT SURVEY; STEM CELL; VIRUS ONCOGENE;

CAENORHABDITIS; CAENORHABDITIS ELEGANS; MAMMALIA; VERTEBRATA;

EID: 0142026089     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.08.011     Document Type: Short Survey

References (89)

1. Guo S., Kemphues K.J. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell. 81:1995;611-620.
2. Montgomery M.K., Xu S., Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 95(26):1998;15502-15507.
3. Fire A.et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391(6669):1998;744-745.
4. Gonczy P.et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature. 408(6810):2000;331-336.
5. Fraser A.G.et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 408(6810):1999;325-330.
6. Baulcombe D. RNA as a target and an initiator of post-transcriptional gene silencing in transgenic plants. Plant Mol. Biol. 32(1-2):1996;79-88.
7. Matzke M.A., Matzke A.J. How and why do plants inactivate homologous (trans)genes? Plant Physiology. 107(3):1995;679-685.
8. Angell S.M., Baulcombe D. Consistent gene silencing in transgenic plants expressing a replicating potato virus X RNA. EMBO J. 16(12):1997;3675-3684.
9. Kumagai M.H.et al. Cytoplasmic inhibition of carotenoid biosynthesis with virus-derived RNA. Proc. Natl. Acad. Sci. USA. 92(5):1995;1679-1683.
10. Wassenegger M.et al. RNA-directed de novo methylation of genomic sequences in plants. Cell. 76(3):1994;567-576.
11. Montgomery M.K., Fire A. Double-stranded RNA as a mediator in sequence-specific genetic silencing and co-suppression. Trends Genet. 14(7):1998;255-258.
12. Palauqui J.C.et al. Systemic acquired silencing: transgene-specific post-transcriptional silencing is transmitted by grafting from silenced stocks to non-silenced scions. EMBO J. 16(15):1997;4738-4745.
13. Caplen N.J.et al. dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene. 252(1-2):2000;95-105.
14. Elbashir S.M.et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20(23):2001;6877-6888.
15. Schwarz D.S.et al. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell. 10(3):2002;537-548.
16. Ui-Tei K.et al. Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett. 479(3):2000;79-82.
17. Enerly E., Larsson J., Lambertsoon A. Reverse genetics in Drosophila: from sequence to phenotype using UAS-RNAi transgenic flies. Genesis. 34(1-2):2002;152-155.
18. Tuschl T.et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13(24):1999;3191-3197.
19. Haley B., Tang G., Zamore P.D. In vitro analysis of RNA interference in Drosophila melanogaster. Methods. 4:2003;330-336.
20. Wu-Scharf D.et al. Transgene and transposon silencing in chlamydomonas reinhardtii by a DEAH-Box RNA helicase. Science. 290:2000;1159-1163.
21. Aravin A.A. Double-stranded RNA-mediated silencing of genomic tandem repeats and transposale elements in the D. melanogaster germline. Curr. Biol. 11:2001;1017-1027.
22. Ketting R.F., Plasterk R.H. A genetic link between co-suppression and RNA interference in C. elegans. Nature. 404:2000;296-298.
23. Ketting R.F.et al. Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell. 99:1999;133-141.
24. Allshire R. Molecular biology. RNAi and heterochromatin - a hushed-up affair. Science. 297(5588):2002;1818-1819.
25. Elbashir S.M.et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411(6836):2001;494-498.
26. Brantl S. Antisense-RNA regulation and RNA interference. Biochim. Biophys. Acta. 1575(1-3):2002;15-25.
27. Erickson R.P. Antisense transgenics in animals. Methods: A Companion Methods Enzymol. (18):1999;304-310.
28. Nagy A., Rossant J. Perspective series: molecular medicine in genetically engineered animals. J. Clin. Invest. 97(6):1999;1360-1365.
29. Aoki Y.et al. RNA interference may be more potent than antisense RNA in human cancer cell lines. Clinical and Experimental Pharmacology and Physiology. 30:2003;96-102.
30. Miyagishi M., Hayashi M., Taira K. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Develop. 13(1):2003;1-7.
31. Llave C.et al. Endogenous and silencing-associated small RNAs in plants. Plant Cell. 14(7):2002;1605-1619.
32. Mourelatos Z.et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16(6):2002;720-728.
33. Pasquinelli A.E. MicroRNAs: deviants no longer. Trends Genet. 18(4):2002;171-173.
34. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:1993;843-854.
35. Pasquinelli A.E.et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 408(6808):2000;86-89.
36. Cox D.N.et al. A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev. 12:1998;3715-3727.
37. Zamore P.D. RNA interference: listening to the sound of silence. Nat. Struct. Biol. 8(9):2001;746-750.
38. Zamore P.D. Ancient pathways programmed by small RNAs. Science. 296(5571):2002;1265-1269.
39. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15(2):2001;188-200.
40. Walters D.K., Jelinek D.F. The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection. Antisense Nucleic Acid Drug Develop. 12:2002;411-418.
41. Lee N.S.et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20(5):2002;500-505.
42. Paul C.P.et al. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20(5):2002;505-508.
43. Sui G.et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA. 99(8):2002;5515-5520.
44. Paddison P.J.et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16(8):2002;948-958.
45. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296(5567):2002;550-553.
46. Yokota T.et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO J. 4(6):2003;1-7.
47. Barton G.M., Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA. 99(23):2002;14943-14945.
48. Devroe E., Silver P.A. Retrovirus-delivered siRNA. BMC Biotechnol. 2(15):2002;1-5.
49. Stewart S.A.et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 9(4):2003;493-501.
50. Abbas-Terki T.et al. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13:2002;2197-2201.
51. Rubinson D.A.et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells, and transgenic mice by RNA interference. Nat. Genet. 33:2003;401-406.
52. Shen C.et al. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. (539):2003;111-114.
53. Ilves H.et al. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study. Gene. 171(2):1996;203-208.
54. Kunkel G.R., Pederson T. Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box. Nucleic Acids Res. 17(18):1989;7371-7379.
55. Myslinski E.et al. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res. 29(12):2001;2502-2509.
56. Zhou A.et al. Identification of NF-kappa B-regulated genes induced by TNF alpha utilizing expression profiling and RNA interference. Oncogene. 22(13):2003;2054-2064.
57. Lassus P., Rodriguez J., Lazebnik Y. Confirming specificity of RNAi in mammalian cells. Sci. STKE. 2002(147):2002;PL13.
58. Shuey D.J., McCallus D.E., Giordano T. RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today. 7(20):2002;1040-1046.
59. Heinonen J.E., Smith C.I., Nore B.F. Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA). FEBS Lett. 527(1-3):2002;274-278.
60. Baranano D.E.et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA. 99(25):2002;16093-16098.
61. Spankuch-Schmitt B.et al. Effect of RNA silencing of polo-like kinase 1 (PLK1) on apoptosis and spindle formation in human cancer cells. J. Natl. Cancer Inst. 94(24):2002;1863-1877.
62. Voorhoeve P.M., Agami R. Knockdown stands up. Trends Biotechnol. 21(1):2003;2-4.
63. Scherr M.et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood. 101(4):2003;1566-1569.
64. Wilda M.et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene. 21(37):2002;5716-5724.
65. Heidenreich O.et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood. 101:2003;3157-3163.
66. Tsuneoka M.et al. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem. 277(38):2002;35450-35459.
67. Brummelkamp T.R., Bernards R., Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2(3):2002;243-247.
68. Bruno S.et al. The PML gene is not involved in the regulation of MHC class I expression in human cell lines. Blood. 101:2003;3514-3519.
69. Jiang M., Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 21(39):2002;6041-6048.
70. Peng Y.et al. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 62(22):2002;6400-6404.
71. Crans-Vargas H.N.et al. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood. 99(7):2002;2617-2619.
72. Yang S.et al. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell. Biol. 21:2001;7807-7816.
73. Hemann M.T.et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33(3):2003;396-400.
74. Lois C.et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:2002;868-872.
75. Pfiefer A.et al. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. USA. 99:2002;2140-2145.
76. Surabhi R.M., Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76(24):2002;12963-12973.
77. Novina C.D.et al. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8(7):2002;681-686.
78. Qin X.F.et al. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA. 100(1):2003;183-188.
79. Silva J.M., Hammond S.M., Hannon G.J. RNA interference: a promising approach to antiviral therapy? Trends Mol. Med. 8(11):2002;505-508.
80. Dector M.A.et al. Rotavirus gene silencing by small interfering RNAs. EMBO Rep. 3(12):2002;1175-1180.
81. Ge Q.et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. PNAS. 100(5):2003;2718-2723.
82. Malhotra P.et al. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Mol. Microbiol. 45(5):2002;1245-1254.
83. Liu H.et al. RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics. 160(2):2002;463-470.
84. Caudy A.A.et al. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16(19):2002;2491-2496.
85. Carthew R.W. RNA interference: the fragile X syndrome connection. Curr. Biol. 12(24):2002;R852-R854.
86. Song E.et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 2003.
87. Tiscornia G.et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA. 100(4):2003;1844-1848.
88. van de Wetering M.et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO J. 4(6):2003;609-615.
89. Allikian M.J.et al. Doxycycline-induced expression of sense and inverted-repeat constructs modulates phosphogluconate mutase (Pgm) gene expression in adult Drosophila melanogaster. Genome Biol. 3(5):2002;1-10.